Detalles de la búsqueda
1.
[68Ga]Ga-NODAGA-TriGalactan, a low molecular weight tracer for the non-invasive imaging of the functional liver reserve.
EJNMMI Radiopharm Chem;
9(1): 41, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750246
2.
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Eur J Nucl Med Mol Imaging;
50(13): 4110-4111, 2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37452871
3.
Effects of Side Chain and Peptide Bond Modifications on the Targeting Properties of Stabilized Minigastrin Analogs.
Pharmaceuticals (Basel);
16(2)2023 Feb 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37052226
4.
Effect of N-Terminal Peptide Modifications on In Vitro and In Vivo Properties of 177Lu-Labeled Peptide Analogs Targeting CCK2R.
Pharmaceutics;
15(3)2023 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-36986657
5.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Eur J Nucl Med Mol Imaging;
50(3): 892-907, 2023 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-36334104
6.
Automated Synthesis of 68Ga-Labeled DOTA-MGS8 and Preclinical Characterization of Cholecystokinin-2 Receptor Targeting.
Molecules;
27(6)2022 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35335396
7.
Radiopharmaceutical Formulation and Preclinical Testing of 68Ga-Labeled DOTA-MGS5 for the Regulatory Approval of a First Exploratory Clinical Trial.
Pharmaceuticals (Basel);
14(6)2021 Jun 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-34208516
8.
Selection of the First 99mTc-Labelled Somatostatin Receptor Subtype 2 Antagonist for Clinical Translation-Preclinical Assessment of Two Optimized Candidates.
Pharmaceuticals (Basel);
14(1)2020 Dec 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33379299
9.
Stabilization Strategies for Linear Minigastrin Analogues: Further Improvements via the Inclusion of Proline into the Peptide Sequence.
J Med Chem;
63(23): 14668-14679, 2020 12 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-33226806
10.
Hybrid Imaging Agents for Pretargeting Applications Based on Fusarinine C-Proof of Concept.
Molecules;
25(9)2020 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32370017
11.
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology.
Pharmaceuticals (Basel);
13(2)2020 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-32019275
12.
Comparison of 68Ga-labeled RGD mono- and multimers based on a clickable siderophore-based scaffold.
Nucl Med Biol;
78-79: 1-10, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31678781
13.
Comparison of PEGylated and non-PEGylated proticles: An in vitro and in vivo study.
Eur J Pharm Sci;
139: 105063, 2019 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31487537
14.
Erratum: Site-specific stabilization of minigastrin analogs against enzymatic degradation for enhanced cholecystokinin-2 receptor targeting: Erratum.
Theranostics;
9(16): 4595-4596, 2019.
Artículo
en Inglés
| MEDLINE | ID: mdl-31367242
15.
Correction: Klingler, M., et al. Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m. Pharmaceuticals 2019, 12, 13.
Pharmaceuticals (Basel);
12(2)2019 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-31200592
16.
Modifying the Siderophore Triacetylfusarinine C for Molecular Imaging of Fungal Infection.
Mol Imaging Biol;
21(6): 1097-1106, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30838551
17.
Rational Design, Synthesis and Preliminary Evaluation of Novel Fusarinine C-Based Chelators for Radiolabeling with Zirconium-89.
Biomolecules;
9(3)2019 03 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30845658
18.
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples.
J Labelled Comp Radiopharm;
62(10): 673-683, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30741441
19.
Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.
Pharmaceuticals (Basel);
12(1)2019 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30650563
20.
DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use.
J Nucl Med;
60(7): 1010-1016, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-30530828